{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-259349","form_type":"8-K","ticker":"ARWR","cik":"0000879407","company_name":"ARROWHEAD PHARMACEUTICALS, INC.","filed_at":"2021-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.044963+00:00","generated_at":"2026-06-29T07:26:01.697684+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Arrowhead Pharmaceuticals announces departure of Chief Commercial Officer James Hassard","bullets":["James Hassard, former Chief Commercial Officer, left the company effective August 23, 2021.","No replacement or interim appointment was disclosed in the filing.","Company thanked Mr. Hassard for his service but provided no reason for departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-259349","json":"https://secwatch.observer/filing/0001193125-21-259349.json","markdown":"https://secwatch.observer/filing/0001193125-21-259349.md","text":"https://secwatch.observer/filing/0001193125-21-259349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/879407/000119312521259349/0001193125-21-259349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/879407/000119312521259349/d184220d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:26:01.697684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c3230ef45","claim":"James Hassard departed as Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC..","evidence_excerpt":"Effective August 23, 2021, James Hassard, the former Chief Commercial Officer of Arrowhead Pharmaceuticals, Inc. (the “Company”) is no longer with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/879407/000119312521259349/0001193125-21-259349-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"left"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}